Cardinal Health Stock Price To Earnings To Growth

CAH Stock

USD 123.42 3.08 2.56%

Cardinal Health fundamentals help investors to digest information that contributes to Cardinal Health's financial success or failures. It also enables traders to predict the movement of Cardinal Stock. The fundamental analysis module provides a way to measure Cardinal Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cardinal Health stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Cardinal Health Company Price To Earnings To Growth Analysis

Cardinal Health's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.

PEG Ratio

PE Ratio

EPS Growth

More About Price To Earnings To Growth | All Equity Analysis

Current Cardinal Health Price To Earnings To Growth

1.02 X

Most of Cardinal Health's fundamental indicators, such as Price To Earnings To Growth, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cardinal Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Cardinal Price To Earnings To Growth Driver Correlations

Understanding the fundamental principles of building solid financial models for Cardinal Health is extremely important. It helps to project a fair market value of Cardinal Stock properly, considering its historical fundamentals such as Price To Earnings To Growth. Since Cardinal Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cardinal Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cardinal Health's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Common Stock	Long Term Debt	Treasury Stock	Property Plant Equipment	Good Will	Current Deferred Revenue	Short Term Investments	Net Tangible Assets	Long Term Debt Total	Long Term Investments	Accumulated Depreciation	Total Permanent Equity	Deferred Long Term Liab	Short Long Term Debt	Net Invested Capital	Cash And Equivalents	Net Working Capital	Capital Stock
Total Assets		-0.28	0.27	-0.17	0.94	0.96	0.97	0.4	0.69	0.93	0.51	0.61	-0.65	0.71	0.71	0.69	0.45	-0.89	0.59	-0.73	-0.18	0.82	0.76	-0.78	-0.67	-0.66	-0.71	0.41
Total Stockholder Equity	-0.28		0.54	0.96	-0.49	-0.53	-0.43	0.25	0.09	-0.59	0.41	0.31	0.73	-0.57	0.3	-0.63	-0.59	0.55	0.33	-0.26	-0.63	-0.39	-0.78	0.29	0.88	0.41	0.71	-0.61
Net Debt	0.27	0.54		0.53	-0.02	0.08	0.04	0.36	0.82	-0.02	0.26	0.78	0.36	0.29	0.8	-0.07	-0.19	-0.23	0.75	-0.24	-0.49	0.35	-0.17	-0.3	0.31	-0.45	-0.06	-0.37
Retained Earnings	-0.17	0.96	0.53		-0.35	-0.42	-0.31	0.27	0.16	-0.45	0.46	0.35	0.54	-0.53	0.33	-0.58	-0.54	0.48	0.37	-0.34	-0.56	-0.28	-0.73	0.14	0.82	0.37	0.61	-0.5
Net Receivables	0.94	-0.49	-0.02	-0.35		0.97	0.98	0.26	0.48	0.98	0.41	0.35	-0.81	0.67	0.45	0.72	0.47	-0.85	0.33	-0.66	0.03	0.75	0.83	-0.68	-0.8	-0.59	-0.78	0.59
Total Liab	0.96	-0.53	0.08	-0.42	0.97		0.98	0.28	0.58	0.99	0.33	0.45	-0.78	0.79	0.54	0.78	0.57	-0.94	0.42	-0.57	0.02	0.84	0.89	-0.77	-0.84	-0.7	-0.83	0.54
Total Current Assets	0.97	-0.43	0.04	-0.31	0.98	0.98		0.37	0.52	0.97	0.44	0.46	-0.76	0.67	0.53	0.72	0.49	-0.86	0.44	-0.68	-0.06	0.78	0.82	-0.73	-0.77	-0.59	-0.74	0.51
Short Term Debt	0.4	0.25	0.36	0.27	0.26	0.28	0.37		0.3	0.22	0.34	0.5	0.02	0.08	0.41	-0.03	-0.13	-0.19	0.54	-0.4	-0.37	0.37	0.01	-0.14	0.05	-0.05	0.0	-0.2
Intangible Assets	0.69	0.09	0.82	0.16	0.48	0.58	0.52	0.3		0.51	0.27	0.82	-0.17	0.67	0.9	0.35	0.18	-0.68	0.8	-0.4	-0.25	0.75	0.34	-0.68	-0.23	-0.79	-0.55	0.12
Accounts Payable	0.93	-0.59	-0.02	-0.45	0.98	0.99	0.97	0.22	0.51		0.3	0.34	-0.85	0.75	0.43	0.78	0.56	-0.9	0.32	-0.54	0.11	0.8	0.88	-0.72	-0.87	-0.68	-0.86	0.61
Common Stock	0.51	0.41	0.26	0.46	0.41	0.33	0.44	0.34	0.27	0.3		0.34	-0.17	0.08	0.5	0.25	0.02	-0.26	0.3	-0.89	-0.59	0.11	0.07	-0.26	0.04	-0.01	0.03	-0.26
Long Term Debt	0.61	0.31	0.78	0.35	0.35	0.45	0.46	0.5	0.82	0.34	0.34		0.06	0.45	0.85	0.18	0.02	-0.46	0.96	-0.45	-0.36	0.62	0.15	-0.64	0.0	-0.46	-0.24	-0.08
Treasury Stock	-0.65	0.73	0.36	0.54	-0.81	-0.78	-0.76	0.02	-0.17	-0.85	-0.17	0.06		-0.56	-0.05	-0.7	-0.6	0.7	0.07	0.31	-0.28	-0.56	-0.78	0.6	0.83	0.42	0.74	-0.55
Property Plant Equipment	0.71	-0.57	0.29	-0.53	0.67	0.79	0.67	0.08	0.67	0.75	0.08	0.45	-0.56		0.5	0.84	0.62	-0.91	0.37	-0.17	0.21	0.8	0.8	-0.72	-0.76	-0.87	-0.87	0.31
Good Will	0.71	0.3	0.8	0.33	0.45	0.54	0.53	0.41	0.9	0.43	0.5	0.85	-0.05	0.5		0.3	0.2	-0.61	0.83	-0.59	-0.52	0.65	0.3	-0.65	-0.11	-0.58	-0.3	-0.03
Current Deferred Revenue	0.69	-0.63	-0.07	-0.58	0.72	0.78	0.72	-0.03	0.35	0.78	0.25	0.18	-0.7	0.84	0.3		0.84	-0.83	0.11	-0.27	0.19	0.61	0.83	-0.61	-0.83	-0.65	-0.79	0.3
Short Term Investments	0.45	-0.59	-0.19	-0.54	0.47	0.57	0.49	-0.13	0.18	0.56	0.02	0.02	-0.6	0.62	0.2	0.84		-0.65	-0.01	-0.02	0.13	0.5	0.69	-0.56	-0.69	-0.44	-0.56	0.21
Net Tangible Assets	-0.89	0.55	-0.23	0.48	-0.85	-0.94	-0.86	-0.19	-0.68	-0.9	-0.26	-0.46	0.7	-0.91	-0.61	-0.83	-0.65		-0.42	0.42	0.02	-0.85	-0.9	0.79	0.83	0.82	0.86	-0.4
Long Term Debt Total	0.59	0.33	0.75	0.37	0.33	0.42	0.44	0.54	0.8	0.32	0.3	0.96	0.07	0.37	0.83	0.11	-0.01	-0.42		-0.46	-0.35	0.58	0.11	-0.55	0.02	-0.45	-0.22	0.01
Long Term Investments	-0.73	-0.26	-0.24	-0.34	-0.66	-0.57	-0.68	-0.4	-0.4	-0.54	-0.89	-0.45	0.31	-0.17	-0.59	-0.27	-0.02	0.42	-0.46		0.54	-0.3	-0.26	0.37	0.16	0.18	0.18	-0.09
Accumulated Depreciation	-0.18	-0.63	-0.49	-0.56	0.03	0.02	-0.06	-0.37	-0.25	0.11	-0.59	-0.36	-0.28	0.21	-0.52	0.19	0.13	0.02	-0.35	0.54		0.07	0.24	0.05	-0.38	-0.09	-0.33	0.58
Total Permanent Equity	0.82	-0.39	0.35	-0.28	0.75	0.84	0.78	0.37	0.75	0.8	0.11	0.62	-0.56	0.8	0.65	0.61	0.5	-0.85	0.58	-0.3	0.07		0.73	-0.79	-0.63	-0.68	-0.71	0.4
Deferred Long Term Liab	0.76	-0.78	-0.17	-0.73	0.83	0.89	0.82	0.01	0.34	0.88	0.07	0.15	-0.78	0.8	0.3	0.83	0.69	-0.9	0.11	-0.26	0.24	0.73		-0.64	-0.97	-0.65	-0.81	0.61
Short Long Term Debt	-0.78	0.29	-0.3	0.14	-0.68	-0.77	-0.73	-0.14	-0.68	-0.72	-0.26	-0.64	0.6	-0.72	-0.65	-0.61	-0.56	0.79	-0.55	0.37	0.05	-0.79	-0.64		0.54	0.62	0.61	-0.27
Net Invested Capital	-0.67	0.88	0.31	0.82	-0.8	-0.84	-0.77	0.05	-0.23	-0.87	0.04	0.0	0.83	-0.76	-0.11	-0.83	-0.69	0.83	0.02	0.16	-0.38	-0.63	-0.97	0.54		0.64	0.86	-0.68
Cash And Equivalents	-0.66	0.41	-0.45	0.37	-0.59	-0.7	-0.59	-0.05	-0.79	-0.68	-0.01	-0.46	0.42	-0.87	-0.58	-0.65	-0.44	0.82	-0.45	0.18	-0.09	-0.68	-0.65	0.62	0.64		0.88	-0.38
Net Working Capital	-0.71	0.71	-0.06	0.61	-0.78	-0.83	-0.74	0.0	-0.55	-0.86	0.03	-0.24	0.74	-0.87	-0.3	-0.79	-0.56	0.86	-0.22	0.18	-0.33	-0.71	-0.81	0.61	0.86	0.88		-0.58
Capital Stock	0.41	-0.61	-0.37	-0.5	0.59	0.54	0.51	-0.2	0.12	0.61	-0.26	-0.08	-0.55	0.31	-0.03	0.3	0.21	-0.4	0.01	-0.09	0.58	0.4	0.61	-0.27	-0.68	-0.38	-0.58

Click cells to compare fundamentals

Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.

Competition

Predict Cardinal Health

Cardinal Price Earnings To Growth Ratio

Price Earnings To Growth Ratio

0.34

As of now, Cardinal Health's Price Earnings To Growth Ratio is decreasing as compared to previous years.

Based on the latest financial disclosure, Cardinal Health has a Price To Earnings To Growth of 1.0175 times. This is 43.31% higher than that of the Health Care Providers & Services sector and 54.98% lower than that of the Health Care industry. The price to earnings to growth for all United States stocks is 79.19% higher than that of the company.

Cardinal Price To Earnings To Growth Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cardinal Health's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cardinal Health could also be used in its relative valuation, which is a method of valuing Cardinal Health by comparing valuation metrics of similar companies.

Cardinal Health is currently under evaluation in price to earnings to growth category among its peers.

Cardinal Health ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Cardinal Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Cardinal Health's managers, analysts, and investors.

Environmental

Governance

Social

Cardinal Fundamentals

	Return On Asset	0.0318
	Profit Margin	0.01 %
	Operating Margin	0.01 %
	Current Valuation	31.42 B
	Shares Outstanding	242.01 M
	Shares Owned By Insiders	0.25 %
	Shares Owned By Institutions	89.33 %
	Number Of Shares Shorted	5.5 M
	Price To Earning	16.00 X
	Price To Book	16.07 X
	Price To Sales	0.13 X
	Revenue	226.83 B
	Gross Profit	6.54 B
	EBITDA	1.98 B
	Net Income	852 M
	Cash And Equivalents	4.04 B
	Cash Per Share	13.32 X
	Total Debt	5.09 B
	Debt To Equity	5.63 %
	Current Ratio	1.04 X
	Book Value Per Share	(13.54) X
	Cash Flow From Operations	3.76 B
	Short Ratio	3.30 X
	Earnings Per Share	5.19 X
	Price To Earnings To Growth	1.02 X
	Target Price	123.82
	Number Of Employees	47.92 K
	Beta	0.62
	Market Capitalization	29.12 B
	Total Asset	45.12 B
	Retained Earnings	(286 M)
	Working Capital	(756 M)
	Current Asset	21.96 B
	Current Liabilities	19.7 B
	Annual Yield	0.02 %
	Five Year Return	3.61 %
	Net Asset	45.12 B
	Last Dividend Paid	2.01

About Cardinal Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Cardinal Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cardinal Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cardinal Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

F	Ford Motor
GOOG	Alphabet Inc Class C
CRM	Salesforce
V	Visa Class A
F	Ford Motor

When determining whether Cardinal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cardinal Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cardinal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cardinal Health Stock:

How To Invest In Cardinal

Details

Is Cardinal Stock a good investment?

Details

What is Cardinal Health's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Cardinal Health Piotroski F Score and Cardinal Health Altman Z Score analysis.

For more detail on how to invest in Cardinal Stock please use our How to Invest in Cardinal Health guide.

You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardinal Health. If investors know Cardinal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardinal Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

48.135

Dividend Share

2.012

Earnings Share

5.19

Revenue Per Share

921.782

Quarterly Revenue Growth

(0.04)

The market value of Cardinal Health is measured differently than its book value, which is the value of Cardinal that is recorded on the company's balance sheet. Investors also form their own opinion of Cardinal Health's value that differs from its market value or its book value, called intrinsic value, which is Cardinal Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardinal Health's market value can be influenced by many factors that don't directly affect Cardinal Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cardinal Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardinal Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardinal Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cardinal Health Stock Price To Earnings To Growth

Cardinal Health Company Price To Earnings To Growth Analysis

PEG Ratio

PE Ratio

EPS Growth

Current Cardinal Health Price To Earnings To Growth

Cardinal Price To Earnings To Growth Driver Correlations

Cardinal Price Earnings To Growth Ratio

Price Earnings To Growth Ratio

0.34

Cardinal Price To Earnings To Growth Peer Comparison

Cardinal Health ESG Sustainability

Cardinal Fundamentals

About Cardinal Health Fundamental Analysis

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY